Cthrc1 deficiency aggravates wound healing and promotes cardiac rupture after myocardial infarction via non-canonical WNT5A signaling pathway. 2023

Di Wang, and Yaping Zhang, and Tianbao Ye, and Runlei Zhang, and Lili Zhang, and Dongmei Shi, and Taixi Li, and Guofang Xia, and Kaifan Niu, and Zhe Zhao, and Yu Chen, and Weijun Pan, and Liang Liu, and Xian Jin, and Chengxing Shen
Department of Cardiology, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, 600 Yishan Road, Shanghai, China.

Cardiac fibroblasts are crucial for scar formation and cardiac repair after myocardial infarction (MI). Collagen triple helix repeat containing 1 (CTHRC1), an extracellular matrix protein, is involved in the pathogenesis of vascular remodeling, bone formation, and tumor progression. However, the role and underlying mechanism of CTHRC1 in post-MI wound repair are not fully clear. Bioinformatics analysis demonstrated CTHRC1 up-regulation in cardiac fibroblasts after ischemic cardiac injury. Serum levels of CTHRC1 were increased in MI mice and CTHRC1 expression was up-regulated in cardiac fibroblasts after MI. In vitro results showed that the induction of CTHRC1 expression in cardiac fibroblasts was mediated by canonical TGFβ1-Smad2/3 signaling axis. Moreover, CTHRC1 improved wound healing and boosted cardiac fibroblast activation in vitro. Cthrc1 deficiency aggravated cardiac function and reduced collagen deposition as well as increased mortality attributable to cardiac rupture after MI. Consistent with above phenotypes, reduced the levels of myocardial CD31, α-smooth muscle actin, collagen I, and collagen III was observed, whereas myocardial expression of matrix metalloproteinase 2 and matrix metalloproteinase 9 were increased in Cthrc1 knockout mice post-MI. Above effects could be partly reversed by rCTHRC1 protein or rWNT5A protein. Our study indicates that cardiac fibroblast-derived, canonical TGFβ1-Smad2/3-dependent CTHRC1 could improve wound repair and prevent cardiac rupture after MI via selectively activating non-canonical WNT5A-PCP signaling pathway.

UI MeSH Term Description Entries
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D003094 Collagen A polypeptide substance comprising about one third of the total protein in mammalian organisms. It is the main constituent of SKIN; CONNECTIVE TISSUE; and the organic substance of bones (BONE AND BONES) and teeth (TOOTH). Avicon,Avitene,Collagen Felt,Collagen Fleece,Collagenfleece,Collastat,Dermodress,Microfibril Collagen Hemostat,Pangen,Zyderm,alpha-Collagen,Collagen Hemostat, Microfibril,alpha Collagen
D005347 Fibroblasts Connective tissue cells which secrete an extracellular matrix rich in collagen and other macromolecules. Fibroblast
D006341 Heart Rupture Disease-related laceration or tearing of tissues of the heart, including the free-wall MYOCARDIUM; HEART SEPTUM; PAPILLARY MUSCLES; CHORDAE TENDINEAE; and any of the HEART VALVES. Pathological rupture usually results from myocardial infarction (HEART RUPTURE, POST-INFARCTION). Cardiac Rupture,Cardiac Free Wall Rupture,Free Wall Rupture, Heart,Ventricular Free Wall Rupture,Cardiac Ruptures,Heart Ruptures
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014945 Wound Healing Restoration of integrity to traumatized tissue. Healing, Wound,Healings, Wound,Wound Healings
D016326 Extracellular Matrix Proteins Macromolecular organic compounds that contain carbon, hydrogen, oxygen, nitrogen, and usually, sulfur. These macromolecules (proteins) form an intricate meshwork in which cells are embedded to construct tissues. Variations in the relative types of macromolecules and their organization determine the type of extracellular matrix, each adapted to the functional requirements of the tissue. The two main classes of macromolecules that form the extracellular matrix are: glycosaminoglycans, usually linked to proteins (proteoglycans), and fibrous proteins (e.g., COLLAGEN; ELASTIN; FIBRONECTINS; and LAMININ). Extracellular Matrix Protein,Matrix Protein, Extracellular,Matrix Proteins, Extracellular,Protein, Extracellular Matrix,Proteins, Extracellular Matrix
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D060449 Wnt Signaling Pathway A complex signaling pathway whose name is derived from the DROSOPHILA Wg gene, and the vertebrate INT gene. The signaling pathway is initiated by the binding of WNT PROTEINS to cell surface WNT RECEPTORS which interact with the AXIN SIGNALING COMPLEX and an array of second messengers that influence the actions of BETA CATENIN. Wnt Signaling,Wnt Pathway,Wnt Pathway, Canonical,Wnt beta-Catenin Signaling Pathway,Canonical Wnt Pathway,Canonical Wnt Pathways,Pathway, Canonical Wnt,Pathway, Wnt,Pathway, Wnt Signaling,Signaling Pathway, Wnt,Signaling, Wnt,Wnt Signaling Pathways,Wnt Signalings,Wnt beta Catenin Signaling Pathway
D018345 Mice, Knockout Strains of mice in which certain GENES of their GENOMES have been disrupted, or "knocked-out". To produce knockouts, using RECOMBINANT DNA technology, the normal DNA sequence of the gene being studied is altered to prevent synthesis of a normal gene product. Cloned cells in which this DNA alteration is successful are then injected into mouse EMBRYOS to produce chimeric mice. The chimeric mice are then bred to yield a strain in which all the cells of the mouse contain the disrupted gene. Knockout mice are used as EXPERIMENTAL ANIMAL MODELS for diseases (DISEASE MODELS, ANIMAL) and to clarify the functions of the genes. Knockout Mice,Mice, Knock-out,Mouse, Knockout,Knock-out Mice,Knockout Mouse,Mice, Knock out

Related Publications

Di Wang, and Yaping Zhang, and Tianbao Ye, and Runlei Zhang, and Lili Zhang, and Dongmei Shi, and Taixi Li, and Guofang Xia, and Kaifan Niu, and Zhe Zhao, and Yu Chen, and Weijun Pan, and Liang Liu, and Xian Jin, and Chengxing Shen
March 2006, Circulation,
Di Wang, and Yaping Zhang, and Tianbao Ye, and Runlei Zhang, and Lili Zhang, and Dongmei Shi, and Taixi Li, and Guofang Xia, and Kaifan Niu, and Zhe Zhao, and Yu Chen, and Weijun Pan, and Liang Liu, and Xian Jin, and Chengxing Shen
November 2017, Oncotarget,
Di Wang, and Yaping Zhang, and Tianbao Ye, and Runlei Zhang, and Lili Zhang, and Dongmei Shi, and Taixi Li, and Guofang Xia, and Kaifan Niu, and Zhe Zhao, and Yu Chen, and Weijun Pan, and Liang Liu, and Xian Jin, and Chengxing Shen
October 2014, International journal of cardiology,
Di Wang, and Yaping Zhang, and Tianbao Ye, and Runlei Zhang, and Lili Zhang, and Dongmei Shi, and Taixi Li, and Guofang Xia, and Kaifan Niu, and Zhe Zhao, and Yu Chen, and Weijun Pan, and Liang Liu, and Xian Jin, and Chengxing Shen
December 2006, PloS one,
Di Wang, and Yaping Zhang, and Tianbao Ye, and Runlei Zhang, and Lili Zhang, and Dongmei Shi, and Taixi Li, and Guofang Xia, and Kaifan Niu, and Zhe Zhao, and Yu Chen, and Weijun Pan, and Liang Liu, and Xian Jin, and Chengxing Shen
April 2022, Nature communications,
Di Wang, and Yaping Zhang, and Tianbao Ye, and Runlei Zhang, and Lili Zhang, and Dongmei Shi, and Taixi Li, and Guofang Xia, and Kaifan Niu, and Zhe Zhao, and Yu Chen, and Weijun Pan, and Liang Liu, and Xian Jin, and Chengxing Shen
October 2018, Medical science monitor : international medical journal of experimental and clinical research,
Di Wang, and Yaping Zhang, and Tianbao Ye, and Runlei Zhang, and Lili Zhang, and Dongmei Shi, and Taixi Li, and Guofang Xia, and Kaifan Niu, and Zhe Zhao, and Yu Chen, and Weijun Pan, and Liang Liu, and Xian Jin, and Chengxing Shen
January 2019, Oxidative medicine and cellular longevity,
Di Wang, and Yaping Zhang, and Tianbao Ye, and Runlei Zhang, and Lili Zhang, and Dongmei Shi, and Taixi Li, and Guofang Xia, and Kaifan Niu, and Zhe Zhao, and Yu Chen, and Weijun Pan, and Liang Liu, and Xian Jin, and Chengxing Shen
September 2023, Cellular signalling,
Di Wang, and Yaping Zhang, and Tianbao Ye, and Runlei Zhang, and Lili Zhang, and Dongmei Shi, and Taixi Li, and Guofang Xia, and Kaifan Niu, and Zhe Zhao, and Yu Chen, and Weijun Pan, and Liang Liu, and Xian Jin, and Chengxing Shen
December 2021, Current opinion in physiology,
Di Wang, and Yaping Zhang, and Tianbao Ye, and Runlei Zhang, and Lili Zhang, and Dongmei Shi, and Taixi Li, and Guofang Xia, and Kaifan Niu, and Zhe Zhao, and Yu Chen, and Weijun Pan, and Liang Liu, and Xian Jin, and Chengxing Shen
May 2022, Journal of thoracic disease,
Copied contents to your clipboard!